Author:
Johnson Rolley E.,McCagh Jeffrey C.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference58 articles.
1. Office of National Drug Control Policy: Policy Paper Opioid Agonist Treatment, March 1999. Washington, DC: Office of National Drug Control Policy; 1999.
2. Office of National Drug Control Policy: The National Drug Control Strategy, 2000. Washington, DC: Office of National Drug Control Policy; 2000.
3. Chiang CN, Hawks R: Development of a buprenorphinenaloxone combination drug for the treatment of drug addiction. In Problems of Drug Dependence. Edited by Harris LS. Washington, DC: Government Printing Office.NIDA Research Monograph No. 141. 1993, 458.
4. O’Connor PG, Oliveto AH, Shi JM, et al.: A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. Am J Drug Alcohol Abuse 1996, 22:523–531.
5. O’Connor PG, Oliveto AH, Shi JM, et al.: A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med 1998, 105:100–105. In a primary care setting retention was higher and continuous opioid abstinence and opioid use were lower compared with a traditional drug treatment setting. This study demonstrated that buprenorphine treatment is effective in a primary care setting.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献